Postpartum Hypertension Study: Nifedipine vs. Enalapril
This study is comparing two common medications, Nifedipine and Enalapril, for managing high blood pressure (hypertension) after childbirth. Researchers want to see if these two drugs are equally effective in preventing hospital readmissions within six weeks of delivery. You may be able to join if you are a woman aged 19 or older, admitted for delivery at 24 weeks gestation or more, and have high blood pressure related to pregnancy or chronic high blood pressure. This study is currently recruiting about 850 participants.
- Study design
- This is an open-label, randomized controlled trial comparing Nifedipine and Enalapril. It aims to enroll about 850 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for hospital readmission within 6 weeks of delivery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Postpartum Evaluation of Nifedipine and Enalapril for Hypertension
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Todd Lovgren, MD · PRINCIPAL_INVESTIGATOR · Nebraska Methodist Health System
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Hospital ReadmissionWithin 6 weeks of delivery
Number of participants meeting criteria for hospital admission.